All Stories

  1. MASS-FIX may allow identification of patients at risk for light chain amyloidosis before the onset of symptoms

    Article • American Journal of Hematology, September 2018, Wiley

    David Barnidge

  2. The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic

    Article • American Journal of Hematology, June 2017, Wiley

    David Barnidge

  3. Assessment of renal response with urinary exosomes in patients with AL amyloidosis: A proof of concept

    Article • American Journal of Hematology, May 2017, Wiley

    David Barnidge

  4. Comprehensive Assessment of M-Proteins Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry

    Article • Clinical Chemistry, August 2016, AACC

    David Barnidge

  5. Screening Method for M-Proteins in Serum Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry

    Article • Clinical Chemistry, August 2016, AACC

    David Barnidge, Dr Maria Alice V Willrich

  6. Monitoring free light chains in serum using mass spectrometry

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2016, De Gruyter

    David Barnidge

  7. Clonotypic Light Chain Peptides Identified for Monitoring Minimal Residual Disease in Multiple Myeloma without Bone Marrow Aspiration

    Article • Clinical Chemistry, October 2015, AACC

    David Barnidge

  8. Using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry to detect monoclonal immunoglobulin light chains in serum and urine

    Article • Rapid Communications in Mass Spectrometry, September 2015, Wiley

    David Barnidge

  9. Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays

    Article • Clinical Chemistry, January 2015, AACC

    David Barnidge, Ravinder Singh